Welcome to the ValueWiki Chelsea Therapeutics International, Ltd. (CHTP) article! Register for free or click the "edit" link to contribute!

Chelsea Therapeutics International, Ltd. (CHTP)

This summary section needs content! Click Here to begin writing.

Have a question about Chelsea Therapeutics International, Ltd.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/19/08 7:11 am	Chelsea Therapeutics Completes Enrollment in Phase II Trial of Droxidopa in Intradialytic Hypotension (GlobeNewswire)
11/13/08 7:11 am	Chelsea Therapeutics Initiates Phase I Clinical Trial of CH-4051 (GlobeNewswire)
11/12/08 7:11 am	Chelsea Therapeutics to Host Analyst and Institutional Investor Day in New York (GlobeNewswire)
11/11/08 9:11 am	CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Financials (EDGAR Online Financials)
11/06/08 9:11 am	New Star Analyst Rankings for CHELSEA THERAPEUTICS (StarMine)
11/06/08 9:11 am	CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report (EDGAR Online)
11/05/08 7:11 am	Chelsea Therapeutics Reports Third Quarter 2008 Results (GlobeNewswire)
11/05/08 7:11 am	Q3 2008 CHELSEA THERAPEUTICS Earnings Release - Before Market Open (CCBN)
11/03/08 8:11 am	UPDATE - Chelsea Therapeutics neurology drug shows promise (at Reuters)
11/03/08 7:11 am	Chelsea Therapeutics Reports Significant Reduction in Severity of Symptoms During Titration Phase of Pivotal Droxidopa Study in Neurogenic Orthostatic Hypotension (GlobeNewswire)